2007.09.07 - POZN

Pre-market:

POZN - +10% gap a pre m,arketben...

"Pozen Initiates Phase III Program For PN 400

(RTTNews) - Chapel Hill, North Carolina - based development stage drug company Pozen, Inc. (POZN) announced the beginning of a phase III program for PN 40, a fixed dose combination of the proton pump inhibitor, esomeprazole magnesium, with the non steroidal anti-inflammatory drug naproxen. The company expects to file a New Drug Application by the first half of 2009."

Market open:

POZN,CTDC megy...

A POZN 07 SEP 12.5 CALL opciója 0.30 dollárról 1.10 dollárra nőtt, +260%-ot...

Market closed